Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital Zhejiang UniversityNo recent work listed

Linghui Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1595-4478; OpenAlex author ID A5028617332. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper

Papers 2

  1. Preclinical Efficacy of Anti-RON Antibody-Drug Conjugate Zt/g4-MMAE for Targeted Therapy of Pancreatic Cancer Overexpressing RON Receptor Tyrosine Kinase. Co-author DOI 10.1021/acs.molpharmaceut.8b00298↗
  2. HINT2 triggers mitochondrial Ca2+ influx by regulating the mitochondrial Ca2+ uniporter (MCU) complex and enhances gemcitabine apoptotic effect in pancreatic c… Co-author DOI 10.1016/j.canlet.2017.09.020↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hangping Yao · 2 shared papers, 2017–2018 · strength 0.14
  2. Weilin Wang · 2 shared papers, 2017–2018 · strength 0.14
  3. Ming‐Hai Wang · 1 shared paper, 2018 · strength 0.08
  4. Chenyu W Hu · 1 shared paper, 2018 · strength 0.08
  5. Dongkai Zhou · 1 shared paper, 2017 · strength 0.06
  6. Shusen Zheng · 1 shared paper, 2017 · strength 0.06
  7. Wei Song · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.